New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

Neutropenia and febrile neutropenia are two major complications of chemotherapy. Dose reductions, delays in treatment administration, and the use of granulocyte colony-stimulating factors are equally recommended options to preserve absolute neutrophil count in case of chemotherapy regimens bringing...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Clin Risk Manag
Hlavní autoři: Ghidini, Michele, Hahne, Jens Claus, Trevisani, Francesco, Panni, Stefano, Ratti, Margherita, Toppo, Laura, Tomasello, Gianluca
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2016
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4928625/
https://ncbi.nlm.nih.gov/pubmed/27445479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S80732
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky